Ignite Creation Date:
2025-12-24 @ 4:48 PM
Ignite Modification Date:
2026-02-02 @ 12:03 PM
Study NCT ID:
NCT02785250
Status:
UNKNOWN
Last Update Posted:
2021-06-18
First Post:
2016-05-18
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of DPX-Survivac Therapy in Patients With Recurrent Ovarian Cancer
Sponsor:
ImmunoVaccine Technologies, Inc. (IMV Inc.)
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
ONC-DPX-Survivac-06
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |